Jeremy Grantham's HUM Position Overview
Jeremy Grantham (via Grantham, Mayo, Van Otterloo & Co. LLC) currently holds 35,296 shares of Humana Inc. (HUM) worth $9.04 M, representing 0.02% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Jeremy Grantham has maintained a long-term strategic position in HUM, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2014, adding 732,273 shares. Largest reduction occurred in Q1 2016, reducing 385,300 shares.
Analysis based on 13F filings available since 2013 Q2
Jeremy Grantham's Humana (HUM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Humana (HUM) Trades by Jeremy Grantham
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -6,924 | Reduce 16.40% | 35,296 | $256.13 |
| Q3 2025 | -5,174 | Reduce 10.92% | 42,220 | $260.17 |
| Q2 2025 | +591 | Add 1.26% | 47,394 | $244.48 |
| Q1 2025 | +6,438 | Add 15.95% | 46,803 | $264.60 |
| Q4 2024 | +23,853 | Add 144.46% | 40,365 | $253.71 |
| Q3 2024 | -37,287 | Reduce 69.31% | 16,512 | $316.74 |
| Q2 2024 | +4,524 | Add 9.18% | 53,799 | $373.65 |
| Q1 2024 | +16,837 | Add 51.91% | 49,275 | $346.72 |
| Q4 2023 | +2,955 | Add 10.02% | 32,438 | $457.81 |
| Q3 2023 | +22,760 | Add 338.54% | 29,483 | $486.52 |
| Q2 2023 | -877 | Reduce 11.54% | 6,723 | $447.13 |
| Q1 2023 | -4,200 | Reduce 35.59% | 7,600 | $485.46 |
| Q4 2022 | -2,500 | Reduce 17.48% | 11,800 | $512.19 |
| Q3 2022 | +11,900 | Add 495.83% | 14,300 | $485.17 |
| Q2 2022 | +2,400 | New Buy | 2,400 | $467.92 |
| Q2 2020 | -74,585 | Sold Out | 0 | $0.00 |
| Q1 2020 | -285,920 | Reduce 79.31% | 74,585 | $314.02 |
| Q4 2019 | +360,505 | New Buy | 360,505 | $366.52 |
| Q2 2019 | -27,700 | Sold Out | 0 | $0.00 |
| Q1 2019 | +3,100 | Add 12.60% | 27,700 | $265.99 |
| Q4 2018 | +24,600 | New Buy | 24,600 | $286.46 |
| Q2 2018 | -171,615 | Sold Out | 0 | $0.00 |
| Q1 2018 | -321,636 | Reduce 65.21% | 171,615 | $268.83 |
| Q4 2017 | -38,424 | Reduce 7.23% | 493,251 | $248.07 |
| Q3 2017 | -37,434 | Reduce 6.58% | 531,675 | $243.63 |
| Q2 2017 | +137,248 | Add 31.78% | 569,109 | $240.62 |
| Q1 2017 | -131,453 | Reduce 23.34% | 431,861 | $206.14 |
| Q4 2016 | -86,223 | Reduce 13.27% | 563,314 | $204.03 |
| Q3 2016 | -6,245 | Reduce 0.95% | 649,537 | $176.89 |
| Q2 2016 | -87,597 | Reduce 11.78% | 655,782 | $179.88 |
| Q1 2016 | -385,300 | Reduce 34.14% | 743,379 | $182.95 |
| Q4 2015 | -238,693 | Reduce 17.46% | 1.13 M | $178.51 |
| Q3 2015 | +431,607 | Add 46.12% | 1.37 M | $179.00 |
| Q2 2015 | -38,300 | Reduce 3.93% | 935,765 | $191.28 |
| Q1 2015 | -132,889 | Reduce 12.00% | 974,065 | $178.02 |
| Q4 2014 | -18,999 | Reduce 1.69% | 1.11 M | $143.63 |
| Q3 2014 | +100,996 | Add 9.85% | 1.13 M | $130.29 |
| Q2 2014 | +120,400 | Add 13.31% | 1.02 M | $127.72 |
| Q1 2014 | +732,273 | Add 425.04% | 904,557 | $112.72 |
| Q4 2013 | +32,180 | Add 22.97% | 172,284 | $103.22 |
| Q3 2013 | +5,565 | Add 4.14% | 140,104 | $93.33 |
| Q2 2013 | +134,539 | Add 0.00% | 134,539 | $84.38 |
Jeremy Grantham's Humana Investment FAQs
Jeremy Grantham first purchased Humana Inc. (HUM) in Q2 2013, acquiring 134,539 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeremy Grantham has held Humana Inc. (HUM) for 42 quarters since Q2 2013.
Jeremy Grantham's largest addition to Humana Inc. (HUM) was in Q1 2014, adding 904,557 shares worth $101.96 M.
According to the latest 13F filing for Q4 2025, Jeremy Grantham's firm, Grantham, Mayo, Van Otterloo & Co. LLC, owns 35,296 shares of Humana Inc. (HUM), valued at approximately $9.04 M.
As of the Q4 2025 filing, Humana Inc. (HUM) represents approximately 0.02% of Jeremy Grantham's publicly disclosed stock portfolio, making it one of their key holdings.
Jeremy Grantham's peak holding in Humana Inc. (HUM) was 1,367,372 shares, as reported at the end of Q3 2015.